Jeffrey M. Burns
Jeffrey M. Burns
Edward H. Hashinger Professor of Neurology
Verified email at - Homepage
Cited by
Cited by
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives
RH Swerdlow, JM Burns, SM Khan
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (8 …, 2014
The Alzheimer's disease mitochondrial cascade hypothesis
RH Swerdlow, JM Burns, SM Khan
Journal of Alzheimer's Disease 20 (s2), S265-S279, 2010
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial
JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ...
Jama 330 (6), 512-527, 2023
Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign
JM Burns, RH Swerdlow
Archives of neurology 60 (3), 437-440, 2003
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Cardiorespiratory fitness and brain atrophy in early Alzheimer disease
JM Burns, BB Cronk, HS Anderson, JE Donnelly, GP Thomas, A Harsha, ...
Neurology 71 (3), 210-216, 2008
Reduced lean mass in early Alzheimer disease and its association with brain atrophy
JM Burns, DK Johnson, A Watts, RH Swerdlow, WM Brooks
Archives of neurology 67 (4), 428-433, 2010
In vivo staging of regional amyloid deposition
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
Progressive posterior cortical dysfunction: a clinicopathologic series
JA Renner, JM Burns, CE Hou, DW McKeel Jr, M Storandt, JC Morris
Neurology 63 (7), 1175-1180, 2004
Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial
JK Morris, ED Vidoni, DK Johnson, A Van Sciver, JD Mahnken, RA Honea, ...
PloS one 12 (2), e0170547, 2017
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
The architecture of the Gram-positive bacterial cell wall
L Pasquina-Lemonche, J Burns, RD Turner, S Kumar, R Tank, N Mullin, ...
Nature 582 (7811), 294-297, 2020
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
Version 3 of the national Alzheimer’s coordinating center’s uniform data set
L Besser, W Kukull, DS Knopman, H Chui, D Galasko, S Weintraub, ...
Alzheimer Disease & Associated Disorders 32 (4), 351-358, 2018
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
TW Schmitz, R Nathan Spreng
Nature communications 7 (1), 13249, 2016
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
MK Taylor, DK Sullivan, JD Mahnken, JM Burns, RH Swerdlow
Alzheimer's & Dementia: Translational Research & Clinical Interventions 4, 28-36, 2018
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease
DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ...
Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010
The system can't perform the operation now. Try again later.
Articles 1–20